Aitchisonia rosea
Aitchisonia rosea · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Aitchisonia rosea is a botanical species recognized for its significant pharmacological potential in traditional medicine. Recent scientific investigations have focused on its diverse biological activities, particularly its promising antidiabetic properties. The plant contains key bioactive compounds, most notably the chemical constituent serverogenin acetate. Researchers often utilize an aqueous extract to isolate these beneficial components for therapeutic study. Understanding these chemical profiles is essential for developing new natural treatments for metabolic disorders.
- Synonyms
- Plocama Rosea
- Common names
- Not available
- Family
- Rubiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Aitchisonia rosea is a plant species that is often identified in botanical literature under a different name. It is formally recognized as having the synonym Plocama rosea, which can sometimes lead to confusion in taxonomic studies. Understanding these nomenclatural links is essential for researchers tracking the distribution and classification of the species. By recognizing both terms, botanists can ensure accuracy when documenting its unique characteristics. This connection highlights the evolving nature of plant naming conventions within the scientific community.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Aitchisonia rosea is a unique botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, it is classified under the class Equisetopsida. The plant is further categorized into the order Gentianales, showcasing its specific evolutionary lineage. It sits within the family Rubiaceae, a group known for its diverse floral characteristics. Ultimately, this species is defined by its placement in the genus Aitchisonia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Rubiaceae |
| Genus | Aitchisonia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aitchisonia rosea exhibits a diverse geographical range that spans across multiple climatic zones in Asia. In the temperate regions of Western Asia, this species can be found growing throughout Afghanistan and Iran. Moving toward more tropical climates, the plant also maintains a significant presence within the Indian Subcontinent. Specifically, its distribution extends into the diverse landscapes of Pakistan. This widespread occurrence highlights the plant's ability to adapt to varying environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aitchisonia rosea is a self-supporting plant that maintains its own structure without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Aitchisonia rosea has demonstrated significant antidiabetic activity through both in-vitro and in-vivo scientific evaluations. Research utilizing α-amylase inhibition assays and oral glucose tolerance tests in diabetic rats confirmed that the plant's aqueous extract can effectively lower blood sugar levels. Detailed GC-MS analysis identified several bioactive phytoconstituents within the plant, specifically highlighting serverogenin acetate and cycloheptasiloxane tetradecamethyl. These specific compounds are believed to serve as the primary agents responsible for the plant's medicinal properties. Ultimately, the findings suggest that A. rosea holds great promise as a natural foundation for the development of new antidiabetic therapeutic drugs.
Compounds
Aitchisonia rosea has demonstrated significant therapeutic potential in recent studies focused on managing diabetes. Through both in-vitro and in-vivo testing, the plant's aqueous extract was shown to effectively lower blood sugar levels and inhibit α-amylase. Detailed GC-MS analysis played a crucial role in identifying the specific bioactive phytoconstituents responsible for these medicinal effects. Notably, the research revealed that Aitchisonia rosea contains serverogenin acetate, which serves as a key antidiabetic agent. These findings suggest that such compounds could eventually be utilized to develop innovative new drugs for diabetic treatment.
Conditions
Aitchisonia rosea demonstrates significant antidiabetic potential by effectively treating alloxan-induced diabetic rats. Through in vivo testing, the aqueous extract of the plant was shown to significantly lower blood sugar levels. This medicinal plant also facilitates a notable reduction in blood glucose concentration during oral glucose tolerance tests. Such therapeutic actions suggest that the bioactive phytoconstituents within the plant are highly effective at managing glycemic control. Consequently, the plant's ability to treat these specific diabetic markers highlights its value as a potential source for new antidiabetic drugs.
Preparations
Aitchisonia rosea is prepared as an aqueous extract to evaluate its therapeutic potential against diabetes. This specific aqueous preparation was utilized in both in-vitro and in-vivo testing to determine its effectiveness. During the α-amylase inhibition assay, the aqueous extract demonstrated significant antidiabetic potential. Furthermore, in-vivo studies using an oral glucose tolerance test showed that rats treated with this aqueous extract experienced a significant reduction in blood glucose levels. The successful application of this aqueous form highlights its utility in identifying bioactive phytoconstituents for drug development.